Tempest Therapeutics Files Prospectus For Offering 2.427M Common Shares On Behalf Of Selling Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 93.5%

Neg 0% Neu 93.5% Pos 0%

https://www.sec.gov/Archives/edgar/data/1544227/000119312526285430/d135184ds3.htm

Comments

No comments yet. Be the first!